Takenaga M - Search Results

1

A novel insulin formulation can keep providing steady levels of insulin for much longer periods in-vivo.

Takenaga M, Yamaguchi Y, Kitagawa A, Ogawa Y, Mizushima Y, Igarashi R. Takenaga M, et al. J Pharm Pharmacol. 2002 Sep;54(9):1189-94. doi: 10.1211/002235702320402026. J Pharm Pharmacol. 2002. PMID: 12356272

2

A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release.

Takenaga M, Yamaguchi Y, Kitagawa A, Ogawa Y, Mizushima Y, Igarashi R. Takenaga M, et al. J Control Release. 2002 Feb 19;79(1-3):81-91. doi: 10.1016/s0168-3659(01)00518-1. J Control Release. 2002. PMID: 11853920

3

[Prolonged release microcapsules of insulin for complement of the basal secretion].

Ogawa Y, Takenaga M, Yamaguchi Y, Igarashi R, Mizushima Y. Ogawa Y, et al. Among authors: takenaga m. Nihon Rinsho. 2002 Sep;60 Suppl 9:542-7. Nihon Rinsho. 2002. PMID: 12387048 Review. Japanese. No abstract available.

4

Optimum formulation for sustained-release insulin.

Takenaga M, Yamaguchi Y, Kitagawa A, Ogawa Y, Kawai S, Mizushima Y, Igarashi R. Takenaga M, et al. Int J Pharm. 2004 Mar 1;271(1-2):85-94. doi: 10.1016/j.ijpharm.2003.10.027. Int J Pharm. 2004. PMID: 15129976

5

Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives.

Yamaguchi Y, Takenaga M, Kitagawa A, Ogawa Y, Mizushima Y, Igarashi R. Yamaguchi Y, et al. Among authors: takenaga m. J Control Release. 2002 Jun 17;81(3):235-49. doi: 10.1016/s0168-3659(02)00060-3. J Control Release. 2002. PMID: 12044564

6

Administration of optimum sustained-insulin release PLGA microcapsules to spontaneous diabetes-prone BB/Wor//Tky rats.

Takenaga M, Yamaguchi Y, Ogawa Y, Kitagawa A, Kawai S, Mizushima Y, Igarashi R, Namae M, Komeda K. Takenaga M, et al. Drug Deliv. 2006 Mar-Apr;13(2):149-57. doi: 10.1080/10717540500315989. Drug Deliv. 2006. PMID: 16423804 Free article.

7

Brain-derived neurotrophic factor bound with lecithin derivative showed a markedly enhanced pharmacological potency due to its potent cell membrane affinity followed by prolonged MAPK activation.

Igarashi R, Nakayama T, Takenaga M, Ichinohe M, Yamaguchi Y, Matsumoto K, Kitagawa A, Nakamura N, Kawai S, Nakagawa T, Taiji M, Nakayama C, Mizushima Y. Igarashi R, et al. Among authors: takenaga m. J Control Release. 2005 Feb 2;102(2):463-73. doi: 10.1016/j.jconrel.2004.10.027. J Control Release. 2005. PMID: 15653164

8

Lecithinized brain-derived neurotrophic factor promotes the differentiation of embryonic stem cells in vitro and in vivo.

Kitagawa A, Nakayama T, Takenaga M, Matsumoto K, Tokura Y, Ohta Y, Ichinohe M, Yamaguchi Y, Suzuki N, Okano H, Igarashi R. Kitagawa A, et al. Among authors: takenaga m. Biochem Biophys Res Commun. 2005 Mar 25;328(4):1051-7. doi: 10.1016/j.bbrc.2005.01.063. Biochem Biophys Res Commun. 2005. PMID: 15707984

9

Successful treatment of photo-damaged skin of nano-scale atRA particles using a novel transdermal delivery.

Yamaguchi Y, Nagasawa T, Nakamura N, Takenaga M, Mizoguchi M, Kawai S, Mizushima Y, Igarashi R. Yamaguchi Y, et al. Among authors: takenaga m. J Control Release. 2005 May 5;104(1):29-40. doi: 10.1016/j.jconrel.2004.11.036. Epub 2005 Apr 20. J Control Release. 2005. PMID: 15866332

10

Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance.

Igarashi R, Hoshino J, Takenaga M, Kawai S, Morizawa Y, Yasuda A, Otani M, Mizushima Y. Igarashi R, et al. Among authors: takenaga m. J Pharmacol Exp Ther. 1992 Sep;262(3):1214-9. J Pharmacol Exp Ther. 1992. PMID: 1527725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters